Unilateral implantation of a new non-diffractive extended range-of-vision IOL in a young patient with Curschmann-Steinert myotonic dystrophy.
Cataract surgery
Extended depth of focus IOL
Myotonic dystrophy
Refractive surgery
Spectacle independence
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
29
10
2020
revised:
01
02
2021
accepted:
04
04
2021
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
18
5
2021
Statut:
epublish
Résumé
We present the case of a 36-year old Curschmann-Steinert myotonic dystrophy patient with posterior subcapsular cataract that we treated with unilateral implantation of an extended depth of focus intraocular lens to address his wish for spectacle independence at far and intermediate distance. The patient underwent phacoemulsification with subsequent implantation of the AcrySof IQ Vivity IOL (Alcon, Fort Worth, TX, USA) in his left eye. Uncorrected distance visual acuity (UDVA) on the left eye increased from +0.40 logMAR preoperatively to -0.12 logMAR at 3 months postoperatively. At the three months follow-up distance corrected intermediate visual acuity (DCIVA) at 80 cm distance was -0.08 logMAR and DCIVA at 66 cm distance was 0.14 logMAR for the left eye. The defocus curve showed a functional defocus of 2.0 diopters at 0.2 logMAR or better, corresponding to the extended depth of focus. Dysphotopsia evaluation with a Halo & Glare simulator (Eyeland-Design Network GmbH, Vreden, Germany) revealed a very low level of photic phenomena. Unilateral implantation of a new generation, non-diffractive extended depth of focus IOL was well tolerated and provided good functional results for far and intermediate distances. The patient reported a very low level of photic phenomena.
Identifiants
pubmed: 33997472
doi: 10.1016/j.ajoc.2021.101109
pii: S2451-9936(21)00118-3
pmc: PMC8094889
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101109Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
G. Auffarth and R. Khoramnia report grants, personal fees and non-financial support from Alcon, Oculus and Johnson&Johnson. This work was supported by an Investigator Initiated Trial Grant IIT# 62791973 from Alcon.
Références
PLoS One. 2020 May 21;15(5):e0233829
pubmed: 32437420
J Cataract Refract Surg. 1998 Sep;24(9):1216-9
pubmed: 9768395
Ophthalmologe. 2000 Nov;97(11):784-7
pubmed: 11130169
Ophthalmologica. 2012;227(4):197-204
pubmed: 22222365
J Refract Surg. 2019 Sep 1;35(9):551-558
pubmed: 31498412
J Refract Surg. 2020 Aug 1;36(8):528-535
pubmed: 32785726
J Cataract Refract Surg. 2009 Jun;35(6):992-7
pubmed: 19465282
J Refract Surg. 2016 Mar;32(3):146-51
pubmed: 27027620
J Refract Surg. 2018 Apr 1;34(4):228-235
pubmed: 29634837
Ophthalmologe. 2020 Dec 10;:
pubmed: 33301065
Ophthalmologe. 2018 Jan;115(1):21-28
pubmed: 28956141
J Cataract Refract Surg. 2015 Dec;41(12):2707-14
pubmed: 26796451
J Refract Surg. 2018 Dec 1;34(12):832-838
pubmed: 30540366
J Cataract Refract Surg. 2013 Jul;39(7):1093-9
pubmed: 23692884
J Cataract Refract Surg. 1993 Sep;19(5):582-9
pubmed: 8229711
J Refract Surg. 2018 Aug 1;34(8):507-514
pubmed: 30089179
J Cataract Refract Surg. 1998 Oct;24(10):1410-2
pubmed: 9795861
J Refract Surg. 2017 Oct 1;33(10):664-669
pubmed: 28991333
Clin Exp Optom. 2008 Sep;91(5):469-72
pubmed: 18201224
J Ophthalmol. 2018 Jan 31;2018:6165493
pubmed: 29651343
Am J Ophthalmol Case Rep. 2020 Mar 17;18:100673
pubmed: 32215345
Ophthalmologe. 2011 Oct;108(10):976-9
pubmed: 21698448
Int Ophthalmol. 2021 Jan;41(1):163-172
pubmed: 32844238
J Refract Surg. 2020 Jul 1;36(7):426-434
pubmed: 32644164
Ophthalmology. 2017 Jan;124(1):139-141
pubmed: 27743644
Curr Opin Ophthalmol. 2018 Jul;29(4):318-322
pubmed: 29697436
Am J Ophthalmol Case Rep. 2020 Aug 20;20:100890
pubmed: 32944673
Am J Ophthalmol. 2020 May;213:322
pubmed: 32145900
J Fr Ophtalmol. 2004 May;27(5):479-83
pubmed: 15179303
BMC Ophthalmol. 2017 Jun 29;17(1):108
pubmed: 28662629
J Refract Surg. 2017 Dec 1;33(12):808-812
pubmed: 29227508
BMC Ophthalmol. 2019 Aug 28;19(1):197
pubmed: 31462225
Am J Ophthalmol. 2011 May;151(5):792-798.e1
pubmed: 21310379
J Cataract Refract Surg. 2015 Aug;41(8):1672-7
pubmed: 26432124
BMC Ophthalmol. 2019 Sep 2;19(1):198
pubmed: 31477053
BMC Ophthalmol. 2020 Feb 14;20(1):53
pubmed: 32059666
J Cataract Refract Surg. 2011 May;37(5):859-65
pubmed: 21397457
J Cataract Refract Surg. 1999 Aug;25(8):1151-6
pubmed: 10445204
J Cataract Refract Surg. 2009 Jun;35(6):1033-9
pubmed: 19465289
J Cataract Refract Surg. 2013 Apr;39(4):642-4
pubmed: 23522586
Sao Paulo Med J. 2015 Feb;133(1):68
pubmed: 25626855
Klin Monbl Augenheilkd. 2007 Jan;224(1):70-5
pubmed: 17260325
Clin Ophthalmol. 2011;5:1281-5
pubmed: 21966202
Am J Ophthalmol. 2019 Dec;208:56-63
pubmed: 31323200
BMC Ophthalmol. 2019 Aug 19;19(1):187
pubmed: 31426775
Ophthalmology. 2001 Nov;108(11):2011-7
pubmed: 11713071
Clin Exp Ophthalmol. 2004 Dec;32(6):653-5
pubmed: 15575838
J Med Genet. 1992 Nov;29(11):774-9
pubmed: 1453425
J Cataract Refract Surg. 2002 Jun;28(6):1012-7
pubmed: 12036646
J Cataract Refract Surg. 1997 Dec;23(10):1532-8
pubmed: 9456412
J Refract Surg. 2019 Aug 1;35(8):484-492
pubmed: 31393986
J Cataract Refract Surg. 2020 Jan;46(1):108-115
pubmed: 32050240